PATRICIA ESMERALDA
CARREIRA DELGADO
Profesora asociada de Ciencias de la Salud
Oslo University Hospital
Oslo, NoruegaPublicaciones en colaboración con investigadores/as de Oslo University Hospital (32)
2024
-
Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?
Arthritis Care and Research, Vol. 76, Núm. 1, pp. 88-97
2023
-
Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research
Chest, Vol. 163, Núm. 3, pp. 586-598
-
Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database
JAMA dermatology, Vol. 159, Núm. 8, pp. 837-847
-
Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database
Rheumatology (Oxford, England), Vol. 62, Núm. 4, pp. 1559-1567
-
Sex influence on outcomes of patients with systemic sclerosis-associated interstitial lung disease: A EUSTAR database analysis
Rheumatology (United Kingdom), Vol. 62, Núm. 7, pp. 2483-2491
2022
-
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis
npj Genomic Medicine, Vol. 7, Núm. 1
-
Development and validation of a patient-reported outcome measure for systemic sclerosis: the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaire
Annals of the rheumatic diseases, Vol. 81, Núm. 4, pp. 507-515
-
Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort
The Lancet Rheumatology, Vol. 4, Núm. 11, pp. e785-e794
2021
-
Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database
Rheumatology (Oxford, England), Vol. 61, Núm. 1, pp. 213-222
-
The burden of systemic sclerosis in Switzerland - the Swiss systemic sclerosis EUSTAR cohort
Swiss medical weekly, Vol. 151, pp. w20528
2020
-
The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements
The Lancet Rheumatology, Vol. 2, Núm. 2, pp. e71-e83
2019
-
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
Nature Communications, Vol. 10, Núm. 1
2018
-
Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: The European Scleroderma Observational Study
Rheumatology (United Kingdom), Vol. 57, Núm. 2, pp. 370-381
-
Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study
Annals of the Rheumatic Diseases, Vol. 77, Núm. 4, pp. 563-570
2017
-
An MIF promoter polymorphism is associated with susceptibility to pulmonary arterial hypertension in diffuse cutaneous systemic sclerosis
Journal of Rheumatology, Vol. 44, Núm. 10, pp. 1453-1457
-
Treatment outcome in early diffuse cutaneous systemic sclerosis: The European Scleroderma Observational Study (ESOS)
Annals of the Rheumatic Diseases, Vol. 76, Núm. 7, pp. 1207-1218
-
Update of EULAR recommendations for the treatment of systemic sclerosis
Annals of the Rheumatic Diseases, Vol. 76, Núm. 8, pp. 1327-1339
2016
-
Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies
Arthritis and Rheumatology, Vol. 68, Núm. 9, pp. 2338-2344
2015
-
A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study
Microvascular Research, Vol. 102, pp. 19-24
-
Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database
Annals of the Rheumatic Diseases, Vol. 74, Núm. 6, pp. 1124-1131